PFO
LMAT icon

Pathstone Family Office’s LeMaitre Vascular LMAT Stock Holding History

Pathstone Family Office’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-7
Closed – – 1042
2020
Q4 		$0 Hold
7
– – ﹤0.01% 1251
2020
Q3 		$0 Sell
7
-7
-50% -$210 ﹤0.01% 908
2020
Q2 		$0 Buy
+14
New +$366 ﹤0.01% 860

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
SCA
Summit Creek Advisors Minneapolis, Minnesota $487M AUM 11.23% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Pathstone Family Office's LMAT Position: Q1 2021 in Review

Pathstone Family Office sold out of LeMaitre Vascular (LMAT) in Q1 2021, closing a stake of 7 shares.

Pathstone Family Office first reported a position in LMAT in Q2 2020 and held it in 3 quarters. The position peaked at $0 in Q4 2020. 179 funds tracked by Wall St. Rank hold LMAT as of Q1 2021.

  • Pathstone Family Office reported no remaining LeMaitre Vascular position as of Q1 2021 after selling out during the quarter.
  • Pathstone Family Office sold 7 LeMaitre Vascular shares in Q1 2021.
  • Pathstone Family Office first reported a position in LeMaitre Vascular in Q2 2020 and held it in 3 quarters.
  • Pathstone Family Office's LeMaitre Vascular position peaked at $0 in Q4 2020.
  • 179 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2021.

Based on Pathstone Family Office's 13F filing for Q1 2021, filed 14 May 2021.